Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
3.510
-0.020 (-0.57%)
Nov 20, 2024, 4:00 PM EST - Market closed
Soligenix Employees
As of December 31, 2023, Soligenix had 15 total employees, including 13 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$24,279
Profits / Employee
-$473,274
Market Cap
8.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ATI Physical Therapy | 6,000 |
XWELL | 337 |
IM Cannabis | 95 |
RedHill Biopharma | 53 |
Evaxion Biotech | 49 |
Jaguar Health | 49 |
Vincerx Pharma | 42 |
Vaccinex | 40 |
SNGX News
- 2 days ago - Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma - PRNewsWire
- 6 days ago - Soligenix to Present at November 21st Virtual Investor Summit Microcap Event - Accesswire
- 7 days ago - Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease - PRNewsWire
- 13 days ago - Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results - PRNewsWire
- 4 weeks ago - Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin - PRNewsWire
- 5 weeks ago - Soligenix Invited to Present at Upcoming Investor Conferences - PRNewsWire
- 6 weeks ago - HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference - PRNewsWire
- 7 weeks ago - Soligenix Announces Partnership with Sterling Pharma Solutions - PRNewsWire